NSE filing, NSE: COFORGE. Summary written from the filing by ALFA Finder's alert engine.
Coforge Ltd: key numbers
- Share price
- ₹1,961.90
- Market cap
- ₹86,920 Cr
- Revenue (annual)
- ₹16,403 Cr
- Net profit (annual)
- ₹1,556 Cr
- P/E (TTM)
- 44.1×Sector 22.9×
- Promoter holding
- 0.00%+0.00% QoQ
- FII holding
- 24.75%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Coforge Ltd
All →Coforge Partnership
Coforge announces a community partnership with Chippenham RFC in UK to support rugby, cricket, and local community development. No financial commitment is disclosed in the announcement.
Coforge Business Update
Coforge named a Leader in Everest Group's QE Services PEAK Matrix 2026. The recognition validates its AI-native quality engineering capabilities.
Coforge Earnings Call Transcript: Key Takeaways
Coforge delivered record order intake exceeding $1 billion, led by significant AI embedding and a successful Encore integration.
Coforge Board Meeting Outcome
Coforge Limited's board approved appointment of Price Waterhouse Chartered Accountants LLP as statutory auditor for a 60-month term effective 1 April 2027. The filing is an auditor appointment disclosure under Change in Management.
- Execution
- 60 months from 01-04-2027
Coforge Merger & Restructuring
Coforge's Board noted the completed voluntary liquidation and dissolution of a step-down Italian subsidiary, Digital Mobile Innovations Italy S.R.L. No financial details are disclosed.
Coforge Results Update
Coforge's press release reports quarterly revenue up 53.6% YoY and raises FY27 EBIT margin guidance to 16%. Eight large deals signed this quarter highlight strong momentum.
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date